Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RO7293583 |
Synonyms | |
Therapy Description |
RO7293583 binds to both PRSS1 (TRP1) and CD3, potentially leads to the activation of CD3-expressing cytotoxic T lymphocytes (CTLs) and CTL-mediated killing of TYRP1-expressing tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RO7293583 | RO-7293583|RO 7293583 | CD3 Antibody 99 | RO7293583 binds to both PRSS1 (TRP1) and CD3, potentially leads to the activation of CD3-expressing cytotoxic T lymphocytes (CTLs) and CTL-mediated killing of TYRP1-expressing tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|